Patent · US Active

DNA polymerase variants with reduced exonuclease activity and uses thereof

US8921043B2 · kind B2 · utility

8Cited by
8References
9Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMay 10, 2012
Grant dateDec 30, 2014
Priority date
Expiry dateJul 12, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y207/07007
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Compositions and methods are described to modify Family B DNA polymerases that contain residual exonuclease activity that interferes with sequencing techniques and with detection of single nucleotide polymorphisms. The compositions are mutant proteins with reduced exonuclease activity compared with presently available “exo−” polymerases, and a sensitive screening assay that enables an assessment of exonuclease activity of any synthetic DNA polymerase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.